{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:24:13Z","timestamp":1794673453432,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) affecting 1 in 3500\u20135000 live male newborns is the frequently fatal genetic disease resulted from various mutations in <jats:italic>DMD<\/jats:italic> gene encoding dystrophin protein. About 70% of DMD-causing mutations are exon deletion leading to frameshift of open reading frame and dystrophin deficiency. To facilitate translating human DMD-targeting CRISPR therapeutics into patients, we herein establish a genetically humanized mouse model of DMD by replacing exon 50 and 51 of mouse <jats:italic>Dmd<\/jats:italic> gene with human exon 50 sequence. This humanized mouse model recapitulats patient\u2019s DMD phenotypes of dystrophin deficiency and muscle dysfunction. Furthermore, we target splicing sites in human exon 50 with adenine base editor to induce exon skipping and robustly restored dystrophin expression in heart, tibialis anterior and diaphragm muscles. Importantly, systemic delivery of base editor via adeno-associated virus in the humanized male mouse model improves the muscle function of DMD mice to the similar level of wildtype ones, indicating the therapeutic efficacy of base editing strategy in treating most of DMD types with exon deletion or point mutations via exon-skipping induction.<\/jats:p>","DOI":"10.1038\/s41467-024-50340-x","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T07:02:07Z","timestamp":1721026927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiajia","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7752-2454","authenticated-orcid":false,"given":"Zhifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-5222","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3921-9395","authenticated-orcid":false,"given":"Qingquan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhurui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2040-0081","authenticated-orcid":false,"given":"Linyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-9735","authenticated-orcid":false,"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-0230","authenticated-orcid":false,"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3533-3465","authenticated-orcid":false,"given":"Chunlong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-6157","authenticated-orcid":false,"given":"Guoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"50340_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","volume":"16","author":"S Guiraud","year":"2015","unstructured":"Guiraud, S. et al. The pathogenesis and therapy of muscular dystrophies. Annu. Rev. Genomics Hum. Genet. 16, 281\u2013308 (2015).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"50340_CR2","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","volume":"25","author":"JR Chamberlain","year":"2017","unstructured":"Chamberlain, J. R. & Chamberlain, J. S. Progress toward gene therapy for duchenne muscular dystrophy. Mol. Ther.: J. Am. Soc. Gene Ther. 25, 1125\u20131131 (2017).","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"50340_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen, C. L. et al. The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum. Mutat. 36, 395\u2013402 (2015).","journal-title":"Hum. Mutat."},{"key":"50340_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1080\/15476286.2021.1874161","volume":"18","author":"B Hanson","year":"2021","unstructured":"Hanson, B., Wood, M. J. A. & Roberts, T. C. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing. RNA Biol. 18, 1048\u20131062 (2021).","journal-title":"RNA Biol."},{"key":"50340_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long, C. et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351, 400\u2013403 (2016).","journal-title":"Science"},{"key":"50340_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar, M. et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351, 407\u2013411 (2016).","journal-title":"Science"},{"key":"50340_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson, C. E. et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351, 403\u2013407 (2016).","journal-title":"Science"},{"key":"50340_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"50340_CR9","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cell.2020.10.025","volume":"183","author":"MV Zuccaro","year":"2020","unstructured":"Zuccaro, M. V. et al. Allele-specific chromosome removal after Cas9 cleavage in human embryos. Cell 183, 1650\u20131664.e1615 (2020).","journal-title":"Cell"},{"key":"50340_CR10","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","volume":"40","author":"AD Nahmad","year":"2022","unstructured":"Nahmad, A. D. et al. Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage. Nat. Biotechnol. 40, 1807\u20131813 (2022).","journal-title":"Nat. Biotechnol."},{"key":"50340_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nbt.4148","volume":"36","author":"SM Ryu","year":"2018","unstructured":"Ryu, S. M. et al. Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. Nat. Biotechnol. 36, 536\u2013539 (2018).","journal-title":"Nat. Biotechnol."},{"key":"50340_CR12","doi-asserted-by":"publisher","first-page":"eabg4910","DOI":"10.1126\/sciadv.abg4910","volume":"7","author":"F Chemello","year":"2021","unstructured":"Chemello, F. et al. Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing. Sci. Adv. 7, eabg4910 (2021).","journal-title":"Sci. Adv."},{"key":"50340_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23996-y","volume":"12","author":"L Xu","year":"2021","unstructured":"Xu, L. et al. Efficient precise in vivo base editing in adult dystrophic mice. Nat. Commun. 12, 3719 (2021).","journal-title":"Nat. Commun."},{"key":"50340_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"50340_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan, L. W. et al. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature 589, 608\u2013614 (2021).","journal-title":"Nature"},{"key":"50340_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","volume":"39","author":"T Rothgangl","year":"2021","unstructured":"Rothgangl, T. et al. In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat. Biotechnol. 39, 949\u2013957 (2021).","journal-title":"Nat. Biotechnol."},{"key":"50340_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"CC Liu","year":"2022","unstructured":"Liu, C. C. et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat. Neurosci. 25, 1020\u20131033 (2022).","journal-title":"Nat. Neurosci."},{"key":"50340_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J. S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"50340_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","volume":"90","author":"RM Grady","year":"1997","unstructured":"Grady, R. M. et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729\u2013738 (1997).","journal-title":"Cell"},{"key":"50340_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/genes11030342","volume":"11","author":"KRQ Lim","year":"2020","unstructured":"Lim, K. R. Q., Nguyen, Q., Dzierlega, K., Huang, Y. & Yokota, T. CRISPR-generated animal models of duchenne muscular dystrophy. Genes 11, 342 (2020).","journal-title":"Genes"},{"key":"50340_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JND-170218","volume":"4","author":"CS Young","year":"2017","unstructured":"Young, C. S., Mokhonova, E., Quinonez, M., Pyle, A. D. & Spencer, M. J. Creation of a novel humanized dystrophic mouse model of duchenne muscular dystrophy and application of a CRISPR\/Cas9 gene editing therapy. J. Neuromuscul. Dis. 4, 139\u2013145 (2017).","journal-title":"J. Neuromuscul. Dis."},{"key":"50340_CR22","doi-asserted-by":"publisher","first-page":"e162809","DOI":"10.1172\/JCI162809","volume":"133","author":"G Li","year":"2023","unstructured":"Li, G. et al. Mini-dCas13X-mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy. J. Clin. Investig. 133, e162809 (2023).","journal-title":"J. Clin. Investig."},{"key":"50340_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102165","volume":"35","author":"M Jin","year":"2024","unstructured":"Jin, M. et al. Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse. Mol. Ther. Nucleic Acids 35, 102165 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"50340_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.omtm.2022.11.010","volume":"28","author":"P Wang","year":"2023","unstructured":"Wang, P. et al. Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping. Mol. Ther. Methods Clin. Dev. 28, 40\u201350 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"50340_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","volume":"72","author":"J Yuan","year":"2018","unstructured":"Yuan, J. et al. Genetic modulation of RNA splicing with a CRISPR-guided cytidine deaminase. Mol. Cell 72, 380\u2013394.e387 (2018).","journal-title":"Mol. Cell"},{"key":"50340_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113340","volume":"42","author":"H Qiu","year":"2023","unstructured":"Qiu, H. et al. Efficient exon skipping by base-editor-mediated abrogation of exonic splicing enhancers. Cell Rep. 42, 113340 (2023).","journal-title":"Cell Rep."},{"key":"50340_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12335-x","volume":"10","author":"L Amoasii","year":"2019","unstructured":"Amoasii, L. et al. In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse. Nat. Commun. 10, 4537 (2019).","journal-title":"Nat. Commun."},{"key":"50340_CR28","doi-asserted-by":"publisher","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","volume":"9","author":"L Amoasii","year":"2017","unstructured":"Amoasii, L. et al. Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Sci. Transl. Med. 9, eaan8081 (2017).","journal-title":"Sci. Transl. Med."},{"key":"50340_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","volume":"26","author":"T Koo","year":"2018","unstructured":"Koo, T. et al. Functional rescue of dystrophin deficiency in mice caused by frameshift mutations using Campylobacter jejuni Cas9. Mol. Ther.: J. Am. Soc. Gene Ther. 26, 1529\u20131538 (2018).","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"50340_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav4324","volume":"5","author":"YL Min","year":"2019","unstructured":"Min, Y. L. et al. CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci. Adv. 5, eaav4324 (2019).","journal-title":"Sci. Adv."},{"key":"50340_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay6812","volume":"6","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system. Sci. Adv. 6, eaay6812 (2020).","journal-title":"Sci. Adv."},{"key":"50340_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature24268","volume":"550","author":"JS Chen","year":"2017","unstructured":"Chen, J. S. et al. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 550, 407\u2013410 (2017).","journal-title":"Nature"},{"key":"50340_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aau1549","volume":"362","author":"L Amoasii","year":"2018","unstructured":"Amoasii, L. et al. Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Science 362, 86\u201391 (2018).","journal-title":"Science"},{"key":"50340_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"50340_CR35","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ymthe.2020.05.024","volume":"28","author":"YL Min","year":"2020","unstructured":"Min, Y. L. et al. Correction of three prominent mutations in mouse and human models of duchenne muscular dystrophy by single-cut genome editing. Mol. Ther.: J. Am. Soc. Gene Ther. 28, 2044\u20132055 (2020).","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"50340_CR36","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.121.054628","volume":"144","author":"J Li","year":"2021","unstructured":"Li, J. et al. Therapeutic exon skipping through a CRISPR-guided cytidine deaminase rescues dystrophic cardiomyopathy in vivo. Circulation 144, 1760\u20131776 (2021).","journal-title":"Circulation"},{"key":"50340_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/bs.ctdb.2017.08.003","volume":"126","author":"O Mashinchian","year":"2018","unstructured":"Mashinchian, O., Pisconti, A., Le Moal, E. & Bentzinger, C. F. The muscle stem cell niche in health and disease. Curr. Top. Dev. Biol. 126, 23\u201365 (2018).","journal-title":"Curr. Top. Dev. Biol."},{"key":"50340_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cell.2016.05.053","volume":"165","author":"MW Popp","year":"2016","unstructured":"Popp, M. W. & Maquat, L. E. Leveraging rules of nonsense-mediated mRNA decay for genome engineering and personalized medicine. Cell 165, 1319\u20131322 (2016).","journal-title":"Cell"},{"key":"50340_CR39","doi-asserted-by":"crossref","unstructured":"Martin, M. J. E. J. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10\u201312 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"50340_CR40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50340-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50340-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T07:03:15Z","timestamp":1721026995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50340-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50340"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50340-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"6 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Y. is a founder of HuidaGene Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5927"}}